Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 4,636 All time
- Disclosed funding
- $320.7B 3656 disclosed amounts
- Median round
- $14.6M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| VT Develops intelligent, logic-gated therapeutics for solid tumors | $61M | Series A | Biotech | China | Investors | |
| P Develops AI-enabled cardiac diagnostics platform for ECG interpretation | Undisclosed | Seed | Healthtech | United Kingdom | Investors | |
| TI Terra IndustriesCompany profile Builds autonomous defense systems and infrastructure for countries in the Global South Builds autonomous defense systems and infrastructure for countries in the Global South | $11.8M | Undisclosed | Defense tech | Nigeria | Investors | |
| T Provides spa, bathhouse, leisure, and activity management software | $30M | Series A | Enterprise software | United Kingdom | Investors | |
| N Develops implant for treating articular cartilage defects in the knee | $4.1M | Seed2Seed | Biotech | United States | Investors | |
| AP Develops, constructs, owns, and operates renewable energy assets | $200M | StrategicUndisclosed | Climate tech | United States | Investors | |
| V Provides intelligent software platforms for oncology care | $43M | Undisclosed | Healthtech | United States | Investors | |
| ZI Zepo IntelligenceCompany profile Zepo Intelligence develops workspace security software combining human-risk management and threat monitoring. Zepo Intelligence develops workspace security software combining human-risk management and threat monitoring. | $15M | Seed | Cybersecurity | United States | Investors | |
| MT Mirador TherapeuticsCompany profile Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases | $250M | Series B | Biotech | United States | Investors | |
| A AI4EyesCompany profile AI4Eyes develops AI-assisted imaging and software to help eye-care professionals assess ocular conditions and plan care. AI4Eyes develops AI-assisted imaging and software to help eye-care professionals assess ocular conditions and plan care. | CA$3.7M | Undisclosed | AI | Canada | Investors Undisclosed |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Y Combinator (YC)
Tractian, Blacksmith, Greptile
159rounds5led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
115rounds22led - 3General Catalyst
Tractian, Legora, Different
102rounds13led - 4Lightspeed
Warp Sciences, Different, Zenzap
82rounds9led - 5Sequoia Capital
Warhound, Whop, Blacksmith
71rounds13led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →